Interferon therapy of lymphoproliferative disorders

Changing paradigms in the treatment of chronic lymphocytic leukemia.

Leukemia·2009

Radioisotopic localization of (90)Yttrium-ibritumomab tiuxetan in patients with CD20+ non-Hodgkin's lymphoma.

Molecular imaging and biology·2008

Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.

Leukemia·2005

Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.

Clinical breast cancer·2002

Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression.

Molecular therapy : the journal of the American Society of Gene Therapy·2001

Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.

International journal of cancer·2001

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Seminars in hematology·2026

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Seminars in hematology·2026

Germline predisposition in myeloproliferative neoplasms.

Seminars in hematology·2026

Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge.

Seminars in hematology·2026

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026

Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3-ITD-Positive AML.

Cancer science·2026

Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.

The Journal of experimental medicine·2026

Electrochemiluminescence immunoassay for quantifying ZMA001 in human serum: method development, validation, and clinical pharmacokinetic application.

Bioanalysis·2026

Surgery compared with medical treatment in patients with type A aortic intramural hematoma: a systematic review and meta-analysis.

Journal of thoracic disease·2026

Molecular mechanisms of bacteria-mediated cancer immunotherapy: from intratumoral microbiota to engineered therapeutics.

Frontiers in immunology·2026

Risk stratification for immune checkpoint inhibitor rechallenge after acute kidney injury: towards a precision medicine framework.

Frontiers in immunology·2026

Related Experiment Videos

Interferon therapy of lymphoproliferative disorders

Related Concept Videos

Changing paradigms in the treatment of chronic lymphocytic leukemia.

Radioisotopic localization of (90)Yttrium-ibritumomab tiuxetan in patients with CD20+ non-Hodgkin's lymphoma.

Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.

Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.

Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression.

Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Germline predisposition in myeloproliferative neoplasms.

Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge.

Pain in SCD-Many mechanisms and mysteries.

The many facets of cardiopulmonary complications in sickle cell disease.

Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3-ITD-Positive AML.

Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.

Electrochemiluminescence immunoassay for quantifying ZMA001 in human serum: method development, validation, and clinical pharmacokinetic application.

Surgery compared with medical treatment in patients with type A aortic intramural hematoma: a systematic review and meta-analysis.

Molecular mechanisms of bacteria-mediated cancer immunotherapy: from intratumoral microbiota to engineered therapeutics.

Risk stratification for immune checkpoint inhibitor rechallenge after acute kidney injury: towards a precision medicine framework.

Related Experiment Videos

Interferon therapy of lymphoproliferative disorders

Related Concept Videos

Related Articles